Evidence map›Paper›PMID 29072575›Full record

ArticleeLife2017

A map of human PRDM9 binding provides evidence for novel behaviors of PRDM9 and other zinc-finger proteins in meiosis.

Nicolas Altemose, Nudrat Noor, Emmanuelle Bitoun, Afidalina Tumian, Michael Imbeault, J Ross Chapman, A Radu Aricescu, Simon R Myers

Open access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. metileneNature communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Human acrocentric chromosome short armbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Polymorphic transposable elements contribute to variation in recombination landscapes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Genome research · 2024
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Nicolas AltemoseThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.ORCID http://orcid.org/0000-0002-7231-6026
Nudrat NoorThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Emmanuelle BitounThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Afidalina TumianDepartment of Statistics, University of Oxford, Oxford, United Kingdom.
Michael ImbeaultGlobal Health Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-0073-0922
J Ross ChapmanThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.ORCID http://orcid.org/0000-0002-6477-4254
A Radu AricescuThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-3783-1388
Simon R MyersThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Centre for Human Genetics · GBÉcole Polytechnique Fédérale de Lausanne · CHUniversity of Oxford · GB

Funding

Cancer Research UK 19270Cancer Research UK C52690/A19270Howard Hughes Medical InstituteMedical Research Council MC_UP_1201/15Medical Research Council MR/L009609/1Medical Research Council MR/M009971/1Wellcome TrustWellcome Trust 086817/Z/08/ZWellcome Trust 090532/Z/09/ZWellcome Trust 098387/Z/12/Z
6 · The paper itself

Abstract

PRDM9 binding localizes almost all meiotic recombination sites in humans and mice. However, most PRDM9-bound loci do not become recombination hotspots. To explore factors that affect binding and subsequent recombination outcomes, we mapped human PRDM9 binding sites in a transfected human cell line and measured PRDM9-induced histone modifications. These data reveal varied DNA-binding modalities of PRDM9. We also find that human PRDM9 frequently binds promoters, despite their low recombination rates, and it can activate expression of a small number of genes including

Indexed as

Homologous RecombinationMeiosisBinding SitesChromosome MappingDNAHEK293 CellsHistone-Lysine N-MethyltransferaseHumansProtein BindingProtein MultimerizationDNAHistone-Lysine N-MethyltransferasePRDM9 protein, humanchromosomesevolutionary biologygenesgenomicshumanKRABmeiosisPRDM9recombinationtransposable elementszinc finger protein

Identifiers

PMID29072575
PMCPMC5705219
OpenAlexW2766341255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.